South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant

The African Development Bank has finalised a loan of up to $15 million for South African vaccine manufacturer Biovac, adding to a wider international financing package intended to build Africa’s first end-to-end oral cholera vaccine facility.